February 4, 2024

Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma – Frontiers

December 6, 2023

Merck partners with HiberCell for Phase Ib renal carcinoma trial – Clinical Trials Arena

September 6, 2023

CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity – Journal of Translational Medicine

August 4, 2023

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma – Nature

June 30, 2023

Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression – Frontiers